Skip to main content
. 2016 Jan 23;7(7):8172–8183. doi: 10.18632/oncotarget.6995

Figure 3. Anti-proliferative properties of the identified HIF-1 inhibitors.

Figure 3

Cell viability of ME-180 cells treated with increasing concentrations of PI-103, trametinib, mycophenolate mofetil, and niclosamide for 24, 48, and 72 hours under normoxic condition. Assay data are expressed as mean ± SD from three measurements.